Jazz Pharmaceuticals (JAZZ) Return on Sales: 2009-2025
Historic Return on Sales for Jazz Pharmaceuticals (JAZZ) over the last 16 years, with Sep 2025 value amounting to 0.14%.
- Jazz Pharmaceuticals' Return on Sales rose 2.00% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 2.00%. This contributed to the annual value of 0.14% for FY2024, which is 3.00% up from last year.
- Per Jazz Pharmaceuticals' latest filing, its Return on Sales stood at 0.14% for Q3 2025, which was up 14.27% from 0.12% recorded in Q2 2025.
- In the past 5 years, Jazz Pharmaceuticals' Return on Sales registered a high of 0.21% during Q1 2021, and its lowest value of -0.13% during Q1 2022.
- Over the past 3 years, Jazz Pharmaceuticals' median Return on Sales value was 0.11% (recorded in 2023), while the average stood at 0.08%.
- Per our database at Business Quant, Jazz Pharmaceuticals' Return on Sales crashed by 35bps in 2022 and then climbed by 17bps in 2023.
- Over the past 5 years, Jazz Pharmaceuticals' Return on Sales (Quarterly) stood at -0.11% in 2021, then increased by 5bps to -0.06% in 2022, then climbed by 17bps to 0.11% in 2023, then grew by 3bps to 0.14% in 2024, then climbed by 2bps to 0.14% in 2025.
- Its last three reported values are 0.14% in Q3 2025, 0.12% for Q2 2025, and 0.14% during Q4 2024.